The terms “three months” and “one month” are pivotal. The Revenue’s approach of fixing “three months” at 90 days and “one month” at 30 days assumes a uniform month length. However, the CGST Act does ...
Received European Commission approval for GOHIBIC® (vilobelimab) for the treatment of SARS-CoV-2-induced acute respiratory distress syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback